Cargando…
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906679/ https://www.ncbi.nlm.nih.gov/pubmed/33600756 http://dx.doi.org/10.1016/S1473-3099(21)00058-X |
| _version_ | 1783655341650608128 |
|---|---|
| author | Darvishian, Maryam Sharafkhah, Maryam Poustchi, Hossein Malekzadeh, Reza |
| author_facet | Darvishian, Maryam Sharafkhah, Maryam Poustchi, Hossein Malekzadeh, Reza |
| author_sort | Darvishian, Maryam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7906679 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79066792021-02-26 Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply Darvishian, Maryam Sharafkhah, Maryam Poustchi, Hossein Malekzadeh, Reza Lancet Infect Dis Correspondence Elsevier Ltd. 2021-05 2021-02-15 /pmc/articles/PMC7906679/ /pubmed/33600756 http://dx.doi.org/10.1016/S1473-3099(21)00058-X Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Darvishian, Maryam Sharafkhah, Maryam Poustchi, Hossein Malekzadeh, Reza Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply |
| title | Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply |
| title_full | Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply |
| title_fullStr | Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply |
| title_full_unstemmed | Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply |
| title_short | Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply |
| title_sort | estimates of anti-sars-cov-2 antibody seroprevalence in iran – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906679/ https://www.ncbi.nlm.nih.gov/pubmed/33600756 http://dx.doi.org/10.1016/S1473-3099(21)00058-X |
| work_keys_str_mv | AT darvishianmaryam estimatesofantisarscov2antibodyseroprevalenceiniranauthorsreply AT sharafkhahmaryam estimatesofantisarscov2antibodyseroprevalenceiniranauthorsreply AT poustchihossein estimatesofantisarscov2antibodyseroprevalenceiniranauthorsreply AT malekzadehreza estimatesofantisarscov2antibodyseroprevalenceiniranauthorsreply |